The present disclosure relates to a sustained release body and a method of manufacturing the sustained release body.
In the related art, in order to cause an active ingredient such as an antifungal agent, an antimicrobial agent, or a deodorant to act on a desired object over a long period of time, a sustained release body that vaporizes the active ingredient and gradually releases (sustainedly releases) the vaporized active ingredient to the outside has been proposed. In general, the sustained release body includes an active ingredient layer containing a vaporizable active ingredient on a substrate, and includes a sustained release film on the active ingredient layer. In this sustained release body, the sustained release film sustainedly releases a gas (vaporized gas) of the active ingredient vaporized from the active ingredient layer to the outside. This can cause the active ingredient to act on a desired object over a long period of time.
As such a sustained release body, for example, JP 2017-226188 A discloses a sustained release film in which an active ingredient layer is formed on a surface of a substrate film, and an active ingredient permeation layer is formed on the active ingredient layer. In the sustained release film described in JP 2017-226188 A, the active ingredient permeation layer functions as a sustained release film that sustainedly releases a vaporized gas of an active ingredient generated from the active ingredient layer to the outside.
However, in the conventional sustained release body described above, a gap is generated between the active ingredient layer and the sustained release film as the vaporized active ingredient is sustainedly released. That is, as exemplified in
In that regard, it is desirable to provide a sustained release body that stable sustained release of an active ingredient can be continued over a target long period of time, and a method of manufacturing the sustained release body.
In some embodiments, a sustained release body includes: a substrate containing a vaporizable active ingredient, the substrate having a structure for releasing a vaporized gas of the active ingredient; and a vapor deposition polymerization film directly formed on a first surface that is one end surface of both end surfaces of the substrate in a thickness direction of the substrate, the vapor deposition polymerization film being configured to receive the vaporized gas of the active ingredient from the first surface of the substrate and sustainedly release the vaporized gas.
In some embodiments, a method of manufacturing a sustained release body includes: forming a sustained release film made of a vapor deposition polymerization film on a first surface that is one end surface of both end surfaces of the substrate in a thickness direction of the substrate; and introducing a vaporizable active ingredient into the substrate from a second surface opposite to the first surface, the second surface being another surface of the both end surfaces of the substrate in the thickness direction.
The above and other objects, features, advantages and technical and industrial significance of this disclosure will be better understood by reading the following detailed description of presently preferred embodiments of the disclosure, when considered in connection with the accompanying drawings.
Hereinafter, a preferred embodiment of a sustained release body according to the disclosure and a method of manufacturing the sustained release body will be described in detail with reference to the attached drawings. Note that the disclosure is not limited by the present embodiment. In addition, it should be noted that the drawings are schematic, and a dimensional relationship among elements, a ratio among the elements, and the like may be different from actual ones. Some portions may have different dimensional relationships and ratios among the drawings. In addition, in the drawings, the same components are denoted by the same reference numerals.
Configuration of Sustained Release Body
First, a configuration of a sustained release body according to an embodiment of the disclosure will be described.
Note that, in the present embodiment, for convenience of description, a thickness direction D1 and a width direction D2 of the sustained release body 10 are set, but these directions do not limit the disclosure. One end side (upper side in
The sustained release body 10 according to the present embodiment vaporizes an active ingredient to act on a desired object (not illustrated) and sustainedly releases the vaporized active ingredient to the outside. As illustrated in
As illustrated in
Examples of the porous material constituting the substrate 1 include a porous resin in which many minute pores are formed by subjecting a resin having a solid structure to a treatment such as stretching or perforation, a foamed resin, and a fiber structure. Such a porous material is an advantageous structure from viewpoints of ease of containing the active ingredient 11 and ease of releasing the vaporized gas 11a of the active ingredient 11 because there is a minute space in the porous material and there is a portion connected from the minute space to the outside. In addition, the porous material more preferably has a structure of continuous open cell from a viewpoint that the vaporized gas 11a of the active ingredient 11 is easily released by the continuous open cell in the porous material.
Examples of a resin component constituting the porous resin include a polyester such as polyethylene terephthalate (PET), nylon, polyvinyl chloride, polyethylene, polypropylene, an ethylene-vinyl acetate copolymer, and polytetrafluoroethylene. For example, minute pores in the porous resin can be formed by adding calcium carbonate to polyethylene and stretching the mixture. Examples of the foamed resin include a polyolefin foamed body, a polyurethane foamed body, and a rubber-based foamed body. Examples of the fiber structure include paper, a woven fabric, and a nonwoven fabric.
In addition, the above-described polymer having a non-crystalline portion is a polymer having at least a non-crystalline structure. Examples of the polymer having a non-crystalline portion include a non-crystalline polymer, a mixed polymer of crystal and non-crystal, and rubber. Examples of the non-crystalline polymer constituting the substrate 1 include polystyrene and an acrylic resin. Examples of the acrylic resin include a polymethyl methacrylate resin (PMMA). Examples of the mixed polymer of crystal and non-crystal include a resin having a folded crystal structure in which a crystal structure and a non-crystalline structure are mixed. Examples of the resin having the folded crystal structure include polyethylene, polypropylene, and nylon. Such a non-crystalline structure is an advantageous structure from viewpoints of ease of containing the active ingredient 11 and ease of releasing the vaporized gas 11a of the active ingredient 11 because the active ingredient easily enters and easily permeates a gap between molecular chains.
The active ingredient 11 contained in the substrate 1 is selected according to use of the sustained release body 10. Examples of the active ingredient 11 include various ingredients such as an antifungal agent, an antimicrobial agent, an anticorrosive agent, a rust inhibitor, a deodorant, and a perfume. Alternatively, the active ingredient 11 may be a combination of two or more of these ingredients. Examples of a compound constituting such an active ingredient 11 include hinokitiol, citronellal, green leaf aldehyde (trans-2-hexenal), citronellol, and geraniol. Examples of the use of the sustained release body 10 include use in a box for transportation or storage of an object such as vegetables, fruits, or flowers, and use in packaging of the object. In addition to these, examples of the use of the sustained release body 10 include use in an antifungal sheet (for example, a mildew generation preventing sheet) in house cultivation, an antifungal sheet for measures against tinea in an insole of a shoe sole, an antifungal and deodorant sheet in a footwear box, and an antimicrobial sheet.
Note that the thickness of the substrate 1 is set according to the content of the active ingredient 11, a target sustained release period of the vaporized gas 11a, use of the sustained release body 10, a size at the time of use, and the like. For example, the thickness of the substrate 1 is about 10 μm to several mm.
The sustained release film 2 is a film for sustainedly releasing the active ingredient 11 vaporized from the substrate 1 to the outside. Specifically, as illustrated in
In the present embodiment, the vaporized gas 11a is an active ingredient gas vaporized from the active ingredient 11 in the substrate 1 by volatilization, evaporation, or the like, and as illustrated in
Such a vapor deposition polymerization film constituting the sustained release film 2 can enhance adhesion between the substrate 1 and the sustained release film 2. That is, the front surface 1a of the substrate 1 is an uneven surface having a large number of minute openings through which the vaporized gas 11a of the active ingredient 11 is released. In a case where the sustained release film 2 is made of a vapor deposition polymer, since the sustained release film 2 comes into close contact with the front surface 1a while following unevenness of the front surface 1a, a gap is less likely to be generated between the sustained release film 2 and the substrate 1, and therefore a crack is less likely to be generated in the sustained release film 2. For example, the sustained release film 2 made of a vapor deposition polymerization film is formed by vacuum vapor deposition and polymerization of two or more types of raw material monomers directly on the front surface 1a of the substrate 1.
The sustained release film 2 has a lower gas permeability than the substrate 1 described above. In the disclosure, the gas permeability is defined by a permeation amount of a gas that permeates a region of a unit area of a film or a layer per unit time. The gas permeability has a unit of [g/m2/day]. That is, the sustained release film 2 releases (sustainedly releases) the vaporized gas 11a generated from the active ingredient 11 in the substrate 1 to the outside by reducing the permeation amount of the vaporized gas 11a based on the gas permeability of the substrate 1 to the permeation amount of the vaporized gas 11a based on the gas permeability of the sustained release film 2.
For example, the gas permeability of the substrate 1 can be measured by performing a water vapor permeability test using a measurement sample of the substrate 1. As a result, as an example of the gas permeability of the substrate 1, a water vapor permeation amount of more than 3000 g/m2/day (>> gas permeability of the sustained release film 2) was obtained. In addition, the gas permeability of the sustained release film 2 which is one of the main components of the sustained release body 10 according to the embodiment of the disclosure can be measured by forming the sustained release film 2 on the substrate 1 and then performing a water vapor permeability test similar to that for the substrate 1. As a result, as an example of the gas permeability of the sustained release film 2, a water vapor permeation amount of 467 g/m2/day was obtained. From the above, it could be confirmed that the gas permeability in a case where the sustained release film 2 was formed on the substrate 1 was lower than the gas permeability of only the substrate 1. That is, it is obvious that the sustained release amount of the vaporized gas 11a of the active ingredient 11 from the substrate 1 can be adjusted by the sustained release film 2.
Note that, in the measurement of the gas permeability, as a measurement sample of the sustained release film 2, a film in which a sustained release film (thickness: 4 μm) made of a vapor deposition polymer was formed on a surface of a substrate (thickness: 75 μm) made of a polyethylene porous material was used. As a measurement sample of the substrate 1, a substrate (thickness: 75 μm) made of the polyethylene porous material was used. The water vapor permeation amount was measured under conditions of a temperature of 20 to 40° C. and a relative humidity of 60% RH or 90% RH on the basis of an isobaric method defined in a moisture sensor method (JIS K 7129A).
The thickness of the sustained release film 2 as described above is set in comprehensive consideration of a target sustained release amount of the vaporized gas 11a of the active ingredient 11 (sustained release amount of the vaporized gas 11a sustainably released to the outside from a region of a unit area of the sustained release film 2 per unit time), the type and content of the active ingredient 11, and the like. For example, the thickness of the sustained release film 2 is preferably in a range of 1 μm or more and 900 μm or less. This is because when the thickness of the sustained release film 2 is less than 1 μm, a crack is likely to be generated in the sustained release film 2, and when the thickness of the sustained release film 2 is more than 900 μm, a sustained release property of the sustained release film 2 may be deteriorated.
The barrier layer 3 is for preventing the vaporized gas 11a of the active ingredient 11 from being released from an unintended surface of the sustained release body 10. Specifically, as illustrated in
Examples of the resin constituting the barrier layer 3 described above include a crystalline resin having a solid structure and a rubber. Examples of the crystalline resin include polyester and nylon. Examples of the rubber include a vulcanized rubber, a silicone rubber, and a urethane rubber.
Note that the area of a side surface 1c (an end surface in the width direction D2) of the substrate 1 is extremely smaller than that of the front surface 1a of the substrate 1. Therefore, even if the vaporized gas 11a of the active ingredient 11 is released from the side surface 1c of the substrate 1, the release amount of the vaporized gas 11a from the side surface 1c is negligibly small as compared with the release amount of the vaporized gas 11a from the front surface 1a of the substrate 1.
The adhesive layer 5 is for fixing the sustained release body 10 to a desired use place. Specifically, as illustrated in
The barrier layer 7 is for preventing the vaporized gas 11a of the active ingredient 11 from being sustainedly released during an unintended period of the sustained release body 10. Specifically, as illustrated in
Meanwhile, for example, as illustrated in
Method of Manufacturing Sustained Release Body
Next, a method of manufacturing the sustained release body 10 according to the embodiment of the disclosure will be described.
As illustrated in
An exhaust pipe (not illustrated) communicating with a vacuum pump (not illustrated) is connected to the vacuum tank 31, and the vacuum tank 31 is communicably joined to the housing unit 33 via the connecting unit 32 having a hollow structure. By operation of the vacuum pump of the vacuum tank 31, air inside the film forming apparatus 30 (specifically, inside the vacuum tank 31, the connecting unit 32, and the housing unit 33) is discharged to the outside through the exhaust pipe, whereby the inside of the film forming apparatus 30 is brought into a vacuum state.
In addition, as illustrated in
Furthermore, a roll obtained by winding the belt-shaped substrate 1 to be the substrate 1 of the sustained release body 10 is attached to the unwinding roller 35. The belt-shaped substrate 1 unwound from the unwinding roller 35 is wound on the main roller 34, and the belt-shaped substrate 1 fed from the main roller 34 is wound around the winding roller 36. That is, in the film forming apparatus 30, the belt-shaped substrate 1 is conveyed by a so-called roll-to-roll method from the unwinding roller 35 to the winding roller 36 via the main roller 34. Note that, as illustrated in
Specifically, in step S101 illustrated in
For example, as illustrated in
In such a vapor deposition polymerization film forming unit 37, two or more types of raw material monomers (two types of raw material monomers 40a and 40b in
Examples of the raw material monomer include an amine and an isocyanate. Examples of the amine include tris(2-aminoethyl) amine, diethylenetriamine, dipropylenetriamine, bishexamethylenetriamine, 1,6-diaminohexane, 1,12-diaminododecane, 4,4-diphenyldiaminomethane, 1,4-diaminobenzene, and m-xylylenediamine. Examples of the isocyanate include isophorone diisocyanate, 1,3-bis(isocyanatomethyl) cyclohexane, hexamethylene diisocyanate, dicyclohexylmethane 4,4′-diisocyanate, m-xylylene diisocyanate, and methylene diphenyl 4,4′-diisocyanate.
Examples of the vapor deposition polymerization film constituting the sustained release film 2 include a film of a vapor deposition polymer such as a polyurea resin, a polyamide resin, a polyimide resin, a polyamideimide resin, a polyester resin, a polyazomethine resin, or a polyurethane resin generated by a polymerization reaction between an amine and an isocyanate. Among the vapor deposition polymers described above, the polyurea resin and the polyurethane resin are polymers obtained by a polyaddition reaction, therefore have a feature that no by-product is generated, and thus are suitably used as vapor deposition polymerization films constituting the sustained release film 2. In particular, the polyurea resin is most suitable when used as the sustained release film 2 because the polyurea resin has a high reaction rate, and therefore can shorten a conveyance path length and a conveyance time required for curing after formation of the vapor deposition polymerization film, or does not need an apparatus for accelerating the curing, such as a heater. Note that the sustained release film 2 made of a vapor deposition film may be formed on the front surface 1a of the belt-shaped substrate 1 by vapor-depositing one type of raw material monomer vaporized by heating.
After the sustained release film forming step in step S101 described above is performed, the active ingredient introducing step (step S102) is performed as illustrated in
As illustrated in
In addition, the roll-shaped belt-shaped body 15 attached to the unwinding roller 54 passes through the inside of the application chamber 55, is wound on the winding roller 58, and is wound by rotary drive of the winding roller 58. That is, the belt-shaped body 15 is conveyed by a so-called roll-to-roll method from the unwinding roller 54 to the winding roller 58 via the inside of the application chamber 55.
Specifically, in step S102, first, the roll-shaped belt-shaped body 15 wound in step S101 described above is unwound from the unwinding roller 54 and conveyed in a direction toward the application chamber 55 (a direction indicated by an arrow (3 in
Examples of a method of introducing the active ingredient 11 into the substrate 1 include a wet application method of applying the liquid active ingredient 11. Examples of the wet application method of applying the active ingredient 11 include the dispenser method described above, an inkjet method (inkjet/print printing method), a spin coating method, a dip coating method, a flow coating method, a screen printing method, a die coating method, a wipe coating method, and a gravure roller method.
After the active ingredient introducing step in step S102 described above is performed, the barrier layer forming step (step S103) is performed as illustrated in
As illustrated in
In addition, the roll-shaped belt-shaped body 15 attached to the unwinding roller 64 passes through a space between the pair of pressing rollers 65a and 65b and is wound on the winding roller 67, and is wound by rotary drive of the pressing rollers 65a and 65b and the winding roller 67. That is, the belt-shaped body 15 is conveyed by a so-called roll-to-roll method from the unwinding roller 64 to the winding roller 67 via a space between the pair of pressing rollers 65a and 65b. Note that, as illustrated in
Specifically, in step S103, first, the roll-shaped belt-shaped body 15 wound in step S102 described above is unwound from the unwinding roller 64 and conveyed in a direction toward a space between the pair of pressing rollers 65a and 65b (a direction indicated by an arrow y in
In the present embodiment, the barrier layer film 16a is for forming the barrier layer 7 on the front surface 2a of the sustained release film 2.
The barrier layer film 16b is for forming the barrier layer 3 on the back surface 1b of the substrate 1 containing the active ingredient 11.
When the belt-shaped body 15 unwound from the unwinding roller 64 passes through a space between the pair of pressing rollers 65a and 65b, the adhesive layer 8 of the barrier layer film 16a is pressed against the front surface 2a of the sustained release film 2, and the adhesive layer 4 of the barrier layer film 16b is pressed against the back surface 1b of the substrate 1. Therefore, the belt-shaped body 15 after passing through a space between the pressing rollers 65a and 65b has a laminated structure in which the barrier layer 7, the adhesive layer 8, the sustained release film 2, the substrate 1 containing the active ingredient 11, the adhesive layer 4, the barrier layer 3, the adhesive layer 5, and the protective sheet 6 are laminated in the thickness direction. Thereafter, the belt-shaped body 15 is wound in a roll shape by the winding roller 67, taken out from the pasting apparatus 60 in a state of being wound in a roll shape, and conveyed to the next step.
Note that the treatment of pasting the barrier layer 3 and the treatment of pasting the barrier layer 7 may be performed in parallel as described above in one barrier layer forming step, or a treatment of pasting one of the barrier layers may be performed before a treatment of pasting the other barrier layer. By such a step S103, as illustrated in
After the barrier layer forming step in step S103 described above is performed, the cutting step (step S104) is performed as illustrated in
Specifically, in step S104, first, the belt-shaped body 15 after the barrier layer forming step is performed is set in a cutting apparatus in a state of being wound in a roll shape. This cutting apparatus sequentially cuts the belt-shaped body 15 while pulling out the belt-shaped body 15 from the set roll and conveying the belt-shaped body 15. At this time, for example, as illustrated in
As described above, in the sustained release body 10 according to the embodiment of the disclosure, the sustained release film 2 made of a vapor deposition polymerization film is formed on the front surface 1a out of both end surfaces (front and back surfaces) of the substrate 1 in the thickness direction D1, and the sustained release film 2 is configured to receive the vaporized gas 11a of the vaporizable active ingredient 11 contained in the substrate 1 from the front surface 1a of the substrate 1 and sustainedly release the vaporized gas 11a.
Therefore, the sustained release film 2 is brought into direct close contact with the front surface 1a of the substrate 1 along the minute unevenness of the front surface 1a of the substrate 1, the close contact state between the substrate 1 and the sustained release film 2 is maintained, and the vaporized gas 11a of the active ingredient 11 vaporized from the substrate 1 can be sustainedly released to the outside by the sustained release film 2. This makes it possible to continue sustained release of the vaporized gas 11a of the active ingredient 11 without presence of the active ingredient 11 at a close contact interface between the substrate 1 and the sustained release film 2. Therefore, even if the content of the active ingredient 11 in the substrate 1 decreases with the sustained release of the vaporized gas 11a of the active ingredient 11, it is possible to avoid a situation in which an unintended gap (a gap other than the gas release port on the substrate surface) is generated at the close contact interface between the substrate 1 and the sustained release film 2. As a result, since the sustained release film 2 can be prevented from being damaged by the gap, it is possible to continue sustained release of the vaporized gas 11a of the active ingredient 11 stably over a target long period of time without excessively releasing the vaporized gas 11a of the active ingredient 11 from a damaged portion of the sustained release film 2.
By using the sustained release body 10 as described above, it is possible to cause the active ingredient 11 to act on a desired object over a long period of time, and it is possible to prevent a situation in which fragments of the sustained release film 2 detached from the sustained release body 10 and an excessive amount of the vaporized gas 11a of the active ingredient 11 released from the damaged portion of the sustained release film 2 adhere to the object to damage the object. For example, when an antifungal agent is used as the active ingredient 11 and the antifungal agent vaporized from the sustained release body 10 is caused to act on food such as fruits, it is possible to prevent a situation in which the food is damaged by fragments of the sustained release film 2 or a vaporized gas of the antifungal agent excessively released.
In addition, as a technique for imparting a sustained release function to the substrate surface (active ingredient release surface), it is also conceivable to paste a sustained release film to the substrate surface or to apply a sustained release material to the substrate surface in addition to forming a vapor deposition polymerization film on the substrate surface. However, in a case where a sustained release film manufactured by a method other than vapor deposition polymerization is used, adhesion between the sustained release film and the substrate is significantly poor as compared with the vapor deposition polymerization film, and therefore it is necessary to devise a method such as forming an adhesive layer between the sustained release film and the substrate or bringing the sustained release film into close contact with the substrate surface by heating. As a result, a problem such as a decrease in vaporization ability of the active ingredient occurs. In addition, in a case where a sustained release material is applied to the substrate surface, variation in application thickness occurs, and therefore it is difficult to achieve a uniform sustained release property on the substrate surface. On the other hand, in the disclosure, the minute uneven surface of the substrate that releases the vaporized gas of the active ingredient and the vapor deposition polymerization film having a sustained release property are combined, whereby it is possible to achieve both improvement of adhesion between the substrate surface and the sustained release film and improvement of the sustained release function by the sustained release film, and a crack of the sustained release film is less likely to be generated.
In the method of manufacturing a sustained release body according to the embodiment of the disclosure, the sustained release film forming step of forming the sustained release film 2 made of a vapor deposition polymerization film on the front surface 1a of the substrate 1 is performed, and then the active ingredient introducing step of introducing the vaporizable active ingredient 11 into the substrate 1 from the back surface 1b of the substrate 1 (a surface opposite to the front surface 1a on which the sustained release film 2 is formed) is performed. As a result, it is possible to easily manufacture the sustained release body 10 that exhibits the above-described action and effect.
In addition, since the active ingredient introducing step is performed after the sustained release film forming step to perform these two steps separately, the vaporizable active ingredient does not enter the vacuum chamber (vacuum tank), and as a result, vaporization of the active ingredient under a vacuum state does not occur. Therefore, it is possible to prevent a decrease in yield in manufacture of the sustained release body. In addition, it is possible to prevent the inside of the vacuum chamber from being contaminated by the vaporized active ingredient.
In addition, in the sustained release body 10 and the method of manufacturing the sustained release body 10 according to the embodiment of the disclosure, the barrier layer 3 that blocks the vaporized gas 11a of the active ingredient 11 is formed on the back surface 1b opposite to the front surface 1a (a surface on which the sustained release film 2 is formed) of the substrate 1. Therefore, it is possible to prevent a situation in which the vaporized gas 11a of the active ingredient 11 is unintentionally released from the back surface 1b of the substrate 1, that is, a surface opposite to the front surface 1a from which release (sustained release) of the vaporized gas 11a of the active ingredient 11 is intended. As a result, it is possible to suppress excessive and wasteful release of the vaporized gas 11a of the active ingredient 11 from the sustained release body 10, and it is possible to sustainedly release the vaporized gas 11a of the active ingredient 11 efficiently via the sustained release film 2. As a result, more stable sustained release of the vaporized gas 11a of the active ingredient 11 can be continued over a target long period of time.
Next, the disclosure will be specifically described on the basis of Example. In Example, in order to confirm the effect of the disclosure, the following experiments were performed. Note that the disclosure is not limited to the following Example.
First, in Example, a film obtained by adding calcium carbonate to a polyethylene film having a size of length: 10 cm×width: 10 cm×thickness: 75 μm and stretching the film to make the film porous (porous film) was adopted as a substrate. Next, a sustained release film made of a vapor deposition polymerization film was formed on a first surface (front surface) out of both end surfaces of the porous film in the thickness direction by a known vapor deposition polymerization method using two types of raw material monomers. In Example, diethylenetriamine and 1,3-bis(isocyanatomethyl) cyclohexane were used as the two types of raw material monomers. In this case, the vapor deposition polymerization film constituting the sustained release film of Example is a polyurea resin. Thereafter, a vaporizable active ingredient was introduced into a second surface (back surface) opposite to the first surface (front surface) out of both end surfaces of the porous film in the thickness direction by a dispenser method. In Example, hinokitiol was used as the active ingredient. A sample of Example was prepared as described above.
Meanwhile, in Comparative Example of the disclosure, a polyethylene film having a solid structure and hardly impregnated with the active ingredient was used as the substrate. Note that the size of the substrate in Comparative Example is the same as that in the above-described Example. Next, a vaporizable active ingredient was applied to a first surface out of both end surfaces of the polyethylene film in the thickness direction by a dispenser method, thereby forming an active ingredient layer on the first surface. The active ingredient in Comparative Example is the same as that in the above-described Example. Thereafter, on a surface of the active ingredient layer, a sustained release film made of a vapor deposition polymerization film was formed by a known vapor deposition polymerization method using two types of raw material monomers. The two types of raw material monomers and vapor deposition polymerization film in Comparative Example are the same as those in the above-described Example. A sample of Comparative Example was prepared as described above.
For each of the samples of Example and Comparative Example prepared as described above, an experiment of leaving the samples in a thermostatic bath was performed, and presence or absence of generation of cracks in the sustained release film in each of the samples was thereby evaluated. In this experiment, 20° C. and 30° C. were used as a temperature condition in the thermostatic bath, and normal pressure was used as a pressure condition in the thermostatic bath. In addition, for each of the samples of Example and Comparative Example, presence or absence of generation of cracks in the sustained release film was visually evaluated by a plurality of operators immediately after production and after 48 hours, 168 hours, one month, and three months had elapsed from start of leaving the samples in the thermostatic bath. As a criterion for this visual evaluation, the size of a target crack was defined to be 2 mm or more, and the number of cracks generated per cm2 in the sustained release film of each of the samples was counted. Evaluation results of Example and Comparative Example are illustrated in Table 1. In Table 1, “◯” means that no crack is generated in the sustained release film (the number of cracks generated=0), and “x” means that a crack is generated in the sustained release film (the number of cracks generated ≥1).
As is obvious with reference to Table 1, in the sample of Comparative Example, a crack of the sustained release film was generated after one month had elapsed under the temperature condition of 20° C., and a crack of the sustained release film was generated after 168 hours had elapsed under the temperature condition of 30° C. On the other hand, in the samples of Example, no crack of the sustained release film was generated regardless of the temperature condition of the thermostatic bath even after three months had elapsed from start of leaving the sample. From this evaluation result, it has been confirmed that according to the sustained release body of the disclosure, a stable sustained release amount of the vaporized active ingredient can be continued over a long period of time.
Note that, in the above-described embodiment, the case where the liquid active ingredient 11 is contained in the substrate 1 has been exemplified, but the disclosure is not limited thereto. For example, the solid active ingredient 11 may be contained in the substrate 1, for example, by embedding the solid active ingredient 11 in the substrate 1, and the vaporized gas 11a sublimated from the solid active ingredient 11 may be sustainedly released.
In addition, in the above-described embodiment, the barrier layer 3 that blocks the vaporized gas 11a of the active ingredient 11 is formed on the back surface 1b of the substrate 1, but the disclosure is not limited thereto. For example, the barrier layer 3 may be formed not only on the back surface 1b of the substrate 1 but also on the side surface 1c of the substrate 1. That is, the barrier layer 3 may be configured to cover the back surface 1b and the side surface 1c of the substrate 1 (remaining substrate surfaces excluding the front surface 1a on which the sustained release film 2 is formed). Alternatively, the sustained release film 2 may be formed not only on the front surface 1a of the substrate 1 but also on the side surface 1c of the substrate 1. That is, the sustained release film 2 may be configured to cover the front surface 1a and the side surface 1c of the substrate 1 (remaining substrate surfaces excluding the back surface 1b on which the barrier layer 3 is formed). The vaporized gas 11a of the active ingredient 11 may be thereby sustainedly released from the front surface 1a and the side surface 1c of the substrate 1 via the sustained release film 2.
In addition, in the above-described embodiment, the barrier layer 3 on the back surface 1b of the substrate 1 and the barrier layer 7 on the front surface 2a of the sustained release film 2 are formed in one step (in the barrier layer forming step in step S103 illustrated in
In addition, in the above-described embodiment, the case has been exemplified where a laminate (for example, the barrier layer film 16b) having a laminated structure of the barrier layer 3, the adhesive layer 5, and the like is formed on the back surface 1b of the substrate 1 from the barrier layer 3 side via the adhesive layer 4, but the disclosure is not limited thereto. For example, the barrier layer 3 and the adhesive layer 5 with the protective sheet 6 may be configured separately from each other, the barrier layer 3 may be formed on the back surface 1b of the substrate 1, and then the adhesive layer 5 and the protective sheet 6 may be sequentially formed on the back surface of the barrier layer 3.
In addition, the disclosure is not limited by the sustained release body and the method of manufacturing the sustained release body according to the above-described embodiment, and the disclosure also includes those configured by appropriately combining the above-described components and manufacturing steps. For example, the active ingredient introducing step in step S102 and the barrier layer forming step in step S103 may be performed with one apparatus, or the active ingredient introducing step in step S102, the barrier layer forming step in step S103, and the cutting step in step S104 may be performed with one apparatus. In addition, other embodiments, Example, operation techniques, and the like performed by a person skilled in the art or the like on the basis of the above-described embodiment are all included in the scope of the disclosure.
The disclosure exhibits an effect that stable sustained release of an active ingredient can be continued over a target long period of time.
Although the disclosure has been described with respect to specific embodiments for a complete and clear disclosure, the appended claims are not to be thus limited but are to be construed as embodying all modifications and alternative constructions that may occur to one skilled in the art that fairly fall within the basic teaching herein set forth.
Number | Date | Country | Kind |
---|---|---|---|
2021-010702 | Jan 2021 | JP | national |
This application is a continuation of International Application No. PCT/JP2022/000741, filed on Jan. 12, 2022 which claims the benefit of priority of the prior Japanese Patent Application No. 2021-010702, filed on Jan. 26, 2021, the entire contents of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
Parent | PCT/JP2022/000741 | Jan 2022 | US |
Child | 18358025 | US |